Study of Tiotropium Hydrofluoralkane in Patients With Chronic Obstructive Pulmonary Disease

Study Title
A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease
Teva Identifier
TBB-COPD-20009
ClinicalTrials.gov Identifier
NCT02203474
Study Status
Withdrawn
Trial Condition(s)
Chronic Obstructive Pulmonary Disease | COPD
Interventions
Drug: Tiotropium HFA BAI 5 mcg | Drug: Tiotropium 18 mcg Capsule | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Adult, Older Adult
Age Range
40 Years to 80 Years
Trial Duration
08/01/2014 - 08/01/2014
Phase
Phase 2

Study Type

Interventional